We are live on ! Find out more
RCEL icon

Avita Medical

71 hedge funds and large institutions have $179M invested in Avita Medical in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

725% more call options, than puts

Call options by funds: $33K | Put options by funds: $4K

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

63% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 16

31% more capital invested

Capital invested by funds: $137M → $179M (+$41.9M)

16% more funds holding

Funds holding: 6171 (+10)

7.34% more ownership

Funds ownership: 27.9%35.25% (+7.3%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
1.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
16
Reduced
9
Closed
16
Calls
$33K
Puts
$4K
Net Calls
+$29K
Net Calls Change
+$1.27M
Name Holding Trade Value Shares
Change
Change in
Stake
Qube Research & Technologies (QRT)
76
Qube Research & Technologies (QRT)
United Kingdom
-$452K -22,796 Closed
Jane Street
77
Jane Street
New York
-$413K -20,830 Closed
LP
78
LMR Partners
United Kingdom
-$280K -14,131 Closed
FNBOSM
79
First National Bank of South Miami
Florida
-$99K -5,000 Closed
PCM
80
Pinz Capital Management
New York
-$65K -3,300 Closed
CI
81
Cordant Inc
Oregon
-$40K -2,000 Closed
Pacer Advisors
82
Pacer Advisors
Pennsylvania
-$14K -697 Closed
ACM
83
Allred Capital Management
Texas
-$8.76K -442 Closed
EP
84
Eudaimonia Partners
Tennessee
-$2K -90 Closed
VFA
85
Valeo Financial Advisors
Indiana
-$1K -40 Closed

RCEL Hedge Fund Activity: Q2 2021 in Review

71 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q2 2021, worth a combined $179M — up 31% from $137M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCEL positions and 16 closed out — a net gain of 10 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $25.4M. The largest seller was Millennium Management, exiting entirely with an estimated $5.32M sold.

  • 71 institutional investors held Avita Medical (RCEL) as of Q2 2021, up from 61 in Q1 2021.
  • Funds reported $179M of Avita Medical stock for Q2 2021, up 31% quarter-over-quarter.
  • 26 funds opened new Avita Medical positions in Q2 2021 and 16 closed out, a net change of +10 holders.
  • The largest Avita Medical buyer in Q2 2021 was BlackRock, an estimated $25.4M added.
  • The largest Avita Medical seller in Q2 2021 was Millennium Management, an estimated $5.32M sold.

Based on aggregated 13F filings for Q2 2021.